1. Home
  2. GRFS vs MMED Comparison

GRFS vs MMED Comparison

Compare GRFS & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.21

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Logo MiniMed Group Inc. Common Stock

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.28

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRFS
MMED
Founded
1940
1983
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.7B
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
GRFS
MMED
Price
$8.21
$16.28
Analyst Decision
Buy
Buy
Analyst Count
2
16
Target Price
$10.37
★ $25.33
AVG Volume (30 Days)
699.5K
★ 6.3M
Earning Date
07-28-2022
11-24-2026
Dividend Yield
★ 3.24%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
N/A
Revenue
N/A
★ $3,102,000,000.00
Revenue This Year
$2.18
$10.76
Revenue Next Year
$6.15
$8.51
P/E Ratio
$18.67
★ N/A
Revenue Growth
N/A
★ 14.25
52 Week Low
$6.96
$10.65
52 Week High
$9.77
$24.43

Technical Indicators

Market Signals
Indicator
GRFS
MMED
Relative Strength Index (RSI) 48.74 38.13
Support Level $7.52 $14.70
Resistance Level $8.29 $17.86
Average True Range (ATR) 0.24 0.98
MACD -0.05 -0.10
Stochastic Oscillator 0.54 3.03

Price Performance

Historical Comparison
GRFS
MMED

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

About MMED MiniMed Group Inc. Common Stock

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

Share on Social Networks: